Treatment.com AI Inc.
TRUE
CNSX
| 03/31/2024 | 09/30/2023 | 06/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 28.40K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 28.40K | -- | -- | -- |
| Cost of Revenue | 60.10K | -- | 2.60K | 2.60K | 100.00 |
| Gross Profit | -60.10K | 28.40K | -2.60K | -2.60K | -100.00 |
| SG&A Expenses | 590.30K | 657.40K | 197.70K | 197.70K | 268.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 670.50K | 657.40K | 200.30K | 200.30K | 268.10K |
| Operating Income | -670.50K | -628.90K | -200.30K | -200.30K | -268.10K |
| Income Before Tax | -687.30K | -623.40K | -214.40K | -214.40K | -282.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -687.30K | -623.40K | -214.40K | -214.40K | -282.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -687.30K | -623.40K | -214.40K | -214.40K | -282.00K |
| EBIT | -670.50K | -628.90K | -200.30K | -200.30K | -268.10K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.02 | -0.09 | -0.03 | -0.03 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.06 | -0.02 | -0.02 | -0.03 |
| EPS Diluted | -0.02 | -0.09 | -0.03 | -0.03 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.06 | -0.02 | -0.02 | -0.03 |
| Average Basic Shares Outstanding | 37.30M | 6.93M | 6.63M | 6.63M | 6.63M |
| Average Diluted Shares Outstanding | 37.30M | 6.93M | 6.63M | 6.63M | 6.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
